NURYLBO Trademark

Trademark Overview

On Wednesday, August 14, 2019, a trademark application was filed for NURYLBO with the United States Patent and Trademark Office. The USPTO has given the NURYLBO trademark a serial number of 88579099. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, March 27, 2023. This trademark is owned by Ovid Therapeutics Inc.. The NURYLBO trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of developmental disorders; Pharmaceutical preparations for the treatment of neurological disorders
nurylbo

General Information

Serial Number88579099
Word MarkNURYLBO
Filing DateWednesday, August 14, 2019
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, March 27, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 24, 2019

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of developmental disorders; Pharmaceutical preparations for the treatment of neurological disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, August 29, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameOvid Therapeutics Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10036
Party NameOvid Therapeutics Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10036

Trademark Events

Event DateEvent Description
Monday, March 27, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, March 27, 2023ABANDONMENT - NO USE STATEMENT FILED
Saturday, August 20, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, August 19, 2022SOU EXTENSION 5 GRANTED
Monday, August 8, 2022SOU EXTENSION 5 FILED
Tuesday, August 16, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, August 8, 2022SOU TEAS EXTENSION RECEIVED
Wednesday, February 9, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, February 7, 2022SOU EXTENSION 4 GRANTED
Monday, February 7, 2022SOU EXTENSION 4 FILED
Monday, February 7, 2022SOU TEAS EXTENSION RECEIVED
Saturday, August 14, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, August 12, 2021SOU EXTENSION 3 GRANTED
Thursday, August 12, 2021SOU EXTENSION 3 FILED
Thursday, August 12, 2021SOU TEAS EXTENSION RECEIVED
Saturday, February 13, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, February 11, 2021SOU EXTENSION 2 GRANTED
Thursday, February 11, 2021SOU EXTENSION 2 FILED
Thursday, February 11, 2021SOU TEAS EXTENSION RECEIVED
Wednesday, August 12, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, August 10, 2020SOU EXTENSION 1 GRANTED
Monday, August 10, 2020SOU EXTENSION 1 FILED
Monday, August 10, 2020SOU TEAS EXTENSION RECEIVED
Tuesday, February 18, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 24, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 24, 2019PUBLISHED FOR OPPOSITION
Wednesday, December 4, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, November 18, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, November 13, 2019ASSIGNED TO EXAMINER
Thursday, August 29, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, August 17, 2019NEW APPLICATION ENTERED

Related Keywords

nurylbo disorders pharmaceutical treatment preparations neurological developmental